Analysts Set Expectations for USPH FY2024 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) - Analysts at Barrington Research increased their FY2024 earnings per share (EPS) estimates for U.S. Physical Therapy in a research note issued on Thursday, November 7th. Barrington Research analyst M. Petusky now forecasts that the company will earn $2.49 per share for the year, up from their prior estimate of $2.20. Barrington Research currently has a "Outperform" rating and a $108.00 target price on the stock. The consensus estimate for U.S. Physical Therapy's current full-year earnings is $2.67 per share. Barrington Research also issued estimates for U.S. Physical Therapy's Q3 2025 earnings at $0.62 EPS, FY2025 earnings at $2.52 EPS and FY2026 earnings at $2.88 EPS.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). The company had revenue of $167.19 million for the quarter, compared to analysts' expectations of $163.34 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. U.S. Physical Therapy's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the firm earned $0.76 earnings per share.

Other equities research analysts have also issued reports about the stock. Bank of America reissued a "neutral" rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Wednesday, August 21st.

U.S. Physical Therapy Stock Performance

Shares of USPH traded down $0.55 during trading hours on Monday, reaching $94.54. 126,928 shares of the company traded hands, compared to its average volume of 91,698. The stock has a market capitalization of $1.43 billion, a P/E ratio of 100.57, a P/E/G ratio of 4.40 and a beta of 1.38. The company has a quick ratio of 1.88, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy has a 12-month low of $76.18 and a 12-month high of $113.63. The business has a fifty day moving average price of $83.80 and a 200-day moving average price of $91.31.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be given a $0.44 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.86%. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 187.23%.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,724 shares of the company's stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the business's stock in a transaction on Tuesday, September 3rd. The stock was acquired at an average price of $86.09 per share, with a total value of $172,180.00. Following the acquisition, the director now owns 18,904 shares in the company, valued at $1,627,445.36. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders own 1.70% of the company's stock.

Institutional Trading of U.S. Physical Therapy

Hedge funds have recently made changes to their positions in the company. Canada Pension Plan Investment Board purchased a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at approximately $28,000. Innealta Capital LLC purchased a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at approximately $30,000. Quest Partners LLC grew its stake in shares of U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company's stock valued at $32,000 after buying an additional 337 shares during the period. Quarry LP grew its stake in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company's stock valued at $48,000 after buying an additional 478 shares during the period. Finally, Ridgewood Investments LLC purchased a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at approximately $51,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.